Ionis Pharmaceuticals Stock (NASDAQ: IONS)

Dernières nouvelles pour Ionis Pharmaceuticals (NASDAQ:IONS) Stock

Ionis Pharmaceuticals

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals Inc

Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) has outperformed the market over the past 5 years by 5.53% on an annualized basis producing an average annual return of 19.52%. Currently, Corteva has a market capitalization of $40.43 billion. 
Buying $1000 In CTVA: If an investor had bought $1000 of CTVA stock 5 years ago, it would be worth $2,403.57 today based on a price of $59.20 for CTVA at the time of writing.
<h3>Corteva's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744839914_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

CTVA

$1000 Invested In Corteva 5 Years Ago Would Be Worth This Much Today

General

SKK Holdings Limited Receives Nasdaq Notification Letter Regarding Minimum Price Deficiency

WIIM

Hertz Global shares are trading higher after CNBC's Scott Wapner said Pershing Square's Hertz stake is 19.8%, through shares & swaps.

Earnings

Guidance

MRC Global Announces Preliminary Q1 2025 Results; Sees Revenue Of ~$710M

Ashford Hospitality Trust Expects To Report Occupancy Of ~ 68% For The First Quarter Of 2025 With Average Daily Rate Of ~ $196 Resulting In RevPAR Of ~ $133

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has outperformed the market over the past 10 years by 10.01% on an annualized basis producing an average annual return of 19.64%. Currently, Meta Platforms has a market capitalization of $1.27 trillion. 
Buying $100 In META: If an investor had bought $100 of META stock 10 years ago, it would be worth $604.54 today based on a price of $502.75 for META at the time of writing.
<h3>Meta Platforms's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744839024_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Meta Platforms 10 Years Ago Would Be Worth Today

Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.54 by 3.7 percent. This is a 14.29 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $260.08 million which beat the analyst consensus estimate of $255.22 million by 1.91 percent. This is a 5.56 percent increase over sales of $246.39 million the same period last year.

Earnings Beats

HOMB

Home BancShares Q1 Adj $0.56 Beats $0.54 Estimate, Sales $260.08M Beat $255.22M Estimate

Liberty Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is a 91.67 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $977.46 million which beat the analyst consensus estimate of $954.73 million by 2.38 percent. This is a 8.90 percent decrease over sales of $1.07 billion the same period last year.

Earnings Misses

LBRT

Liberty Energy Q1 Adj EPS $0.04 Misses $0.05 Estimate, Sales $977.46M Beat $954.73M Estimate

Northern Oil and Gas Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) shares are rising in extended trading Wednesday after the company provided an update on first-quarter hedging results <a href="https://www.benzinga.com/pressreleases/25/04/b44852024/nog-provides-update-on-first-quarter-hedging-results-and-shareholder-returns">and shareholder returns</a>.
What Happened: Northern Oil and Gas reported estimated unrealized mark-to-market gains on derivatives of $9 million to $10 million for the first quarter. The unrealized gains were driven primarily by changes to the value of the company&#8217;s oil derivatives portfolio.
Northern Oil And Gas said realized hedge gains were an estimated $11 million to $12 million in the quarter, primarily driven by the company&#8217;s crude oil and Waha basis hedges. 
Northern Oil and Gas noted it added &#8220;substantial&#8221; hedges since its fourth quarter report, including hedges to oil, natural gas and Waha, Midland-Cushing and M2 basis hedges.
The company also provided an update on shareholder returns. Northern Oil and Gas said it paid dividends of approximately $42 million during the first quarter. In February, the company declared a dividend of 45 cents per share, up 7% compared to the prior quarterly dividend. The dividend is payable on April 30.
See Also: <a href="https://www.benzinga.com/news/earnings/25/04/44852989/kinder-morgan-q1-earnings-revenue-beat-eps-miss-forward-guidance-our-company-can-be-a-safe-haven-during-the-storm">Kinder Morgan Q1 Earnings: Revenue Beat, EPS Miss, Forward Guidance — &#8216;Our Company Can Be A Safe Haven During The Storm&#8217;</a>
Northern Oil and Gas also said it repurchased 499,100 shares during the quarter at an average price of $30.07. Year-to-date shareholder returns are currently around $57 million, the company said.
Northern Oil and Gas is scheduled to report first-quarter earnings after the market close on April 29. Analysts are looking for adjusted earnings of 11 cents per share and revenue of $556.94 million, per <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates.
NOG Price Action: <a href="http://benzinga.com/quote/nog">Northern Oil And Gas shares</a> were up 4.43% at $23.95 after-hours at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/color+space+illusion">fotokaleinar</a>/Shutterstock.

Dividends

Commodities

Buybacks

After-Hours Center

Movers

Northern Oil And Gas Stock Climbs On Q1 Hedging Results, Shareholder Return Update: What You Need To Know

Simmons First Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFNC#NASDAQ">SFNC</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.35 by 25.71 percent. This is a 18.75 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $209.58 million which beat the analyst consensus estimate of $209.08 million by 0.24 percent. This is a 7.43 percent increase over sales of $195.09 million the same period last year.

SFNC

Simmons First Ntl Q1 Adj $0.26 Misses $0.35 Estimate, Sales $209.58M Beat $209.08M Estimate

BANL

CBL International FY EPS $(0.136) Down From $0.045 YoY, Sales $592.50M Up From $435.90M YoY

Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) has outperformed the market over the past 10 years by 8.63% on an annualized basis producing an average annual return of 18.26%. Currently, Fiserv has a market capitalization of $117.93 billion. 
Buying $1000 In FI: If an investor had bought $1000 of FI stock 10 years ago, it would be worth $5,376.41 today based on a price of $210.11 for FI at the time of writing.
<h3>Fiserv's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744838116_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

QXO Reveals Its Intention To Make An Offering of $500M Of Shares Of Its Common Stock

Hertz Global Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) shares picked up momentum heading into Wednesday&#8217;s close and have continued to move higher in after-hours trading. Here&#8217;s a look at <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44840772/hertz-stock-zooms-25-pre-market-bill-ackmans-pershing-square-makes-46-5m-bet">what&#8217;s going on</a>.
What To Know: Hertz shares surged Wednesday morning after Bill Ackman's&nbsp;Pershing Square Capital Management filed an&nbsp;<a href="https://www.sec.gov/Archives/edgar/data/1336528/000117266125001497/xslForm13F_X02/infotable.xml" target="_blank" rel="noreferrer noopener">amended 13F</a>&nbsp;showing that the firm purchased 12.71 million shares of the rental car company as of Dec. 31, representing a stake of approximately 4.1%.
About 15 minutes before the market close, CNBC&#8217;s Scott Wapner reported on &#8220;Closing Bell&#8221; that a person familiar with the matter said Ackman&#8217;s firm&#8217;s stake is actually significantly higher at 19.8%, making Pershing Square the second-largest shareholder.
&#8220;I&#8217;m also told that Pershing received a confidential treatment provision from the SEC, which allowed them to delay the filing beyond the normally required reporting period, which gave them the ability to accumulate substantially more shares since the end of December,&#8221; Wapner said.
Wapner noted that Pershing is optimistic about a turnaround under new management. The source also reportedly said Pershing&#8217;s bet is partially a tariff play since used cars aren&#8217;t impacted by tariffs.
Check This Out: <a href="https://www.benzinga.com/news/earnings/25/04/44852539/csx-shares-slide-after-worse-than-expected-q1-results-details">CSX Shares Slide After Worse-Than-Expected Q1 Results: Details</a>
Hertz reported financial results for the fourth quarter in February that fell shy of analyst estimates. The company said at the time that it was focused on "stabilizing the business" and implementing changes to "transform" the company.
Hertz announced this week that it will report first-quarter earnings after the market close on May 12. Analysts currently expect the company to report a loss of 96 cents per share and revenue of $2.01 billion, according to estimates from <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
HTZ Price Action: <a href="http://benzinga.com/quote/htz">Hertz Global shares</a> were up around 20% for the majority of Wednesday&#8217;s session. The stock surged just ahead of the bell, closing the day up 56.44% at $5.71. The stock was up another 16.11% after hours, trading at $6.63 at the time of publication, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/vieninsweden">vieninsweden</a>/Shutterstock.

Hertz Stock Accelerates Into The Close, Shares Continue To Move Higher After Hours: Here's Why

<h3>Gainers</h3>
<ul>
<li>Hertz Global Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) shares moved upwards by 13.8% to $6.5 during Wednesday's after-market session. The company's market cap stands at $1.9 billion. </li>
<li>NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) stock rose 6.7% to $1.75. The market value of their outstanding shares is at $87.4 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares rose 6.68% to $0.24. The company's market cap stands at $6.1 million. </li>
<li>VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) stock rose 6.6% to $2.9. The company's market cap stands at $8.1 million. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) stock rose 6.32% to $0.37. The company's market cap stands at $2.3 million. </li>
<li>Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) shares increased by 5.83% to $0.36. The company's market cap stands at $34.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) stock declined by 5.3% to $2.32 during Wednesday's after-market session. The company's market cap stands at $44.2 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares decreased by 5.17% to $0.65. The market value of their outstanding shares is at $11.6 million. </li>
<li>Freightos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGO#NASDAQ">CRGO</a>) stock declined by 4.53% to $1.9. The company's market cap stands at $95.0 million. </li>
<li>KULR Technology Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares decreased by 3.13% to $1.24. The company's market cap stands at $296.7 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock fell 3.11% to $0.18. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

CRGO

HTOO

KULR

NNBR

SGBX

SRFM

VCIG

WLGS

11 Industrials Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) shares increased by 12.9% to $0.0 during Wednesday's after-market session. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) shares moved upwards by 7.6% to $2.83. The company's market cap stands at $70.3 million. </li>
<li>RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) stock increased by 5.13% to $2.56. The market value of their outstanding shares is at $96.7 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) shares increased by 5.02% to $0.93. The company's market cap stands at $17.8 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) stock rose 5.01% to $0.48. The market value of their outstanding shares is at $6.6 million. </li>
<li>Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) stock rose 4.99% to $0.13. The company's market cap stands at $7.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Charles &amp; Colvard (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTHR#NASDAQ">CTHR</a>) shares decreased by 10.9% to $0.9 during Wednesday's after-market session. The company's market cap stands at $2.7 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) stock decreased by 10.44% to $0.65. The company's market cap stands at $9.4 million. </li>
<li>Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) stock decreased by 7.26% to $2.43. The market value of their outstanding shares is at $3.6 million. </li>
<li>SAG Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) shares declined by 5.09% to $0.91. The company's market cap stands at $8.9 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) stock fell 4.47% to $0.45. The market value of their outstanding shares is at $5.1 million. </li>
<li>Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) stock decreased by 3.78% to $1.26. The market value of their outstanding shares is at $4.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTHR

NAAS

RMBL

SPHL

TOPW

VEEE

WKHS

Connexa Sports Technologies Inc. - Common Stock

YYAI

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock moved upwards by 18.9% to $0.69 during Wednesday's after-market session. The company's market cap stands at $16.4 million. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock increased by 13.99% to $1.14. The company's market cap stands at $15.6 million. </li>
<li>Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) stock rose 10.36% to $0.46. The company's market cap stands at $105.0 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock increased by 9.44% to $0.14. The market value of their outstanding shares is at $1.6 million. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) shares rose 9.38% to $0.41. The company's market cap stands at $21.3 million. </li>
<li>Revelation Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REVB#NASDAQ">REVB</a>) stock increased by 8.33% to $3.25. The company's market cap stands at $2.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aspira Womens Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWH#NASDAQ">AWH</a>) shares decreased by 49.0% to $0.04 during Wednesday's after-market session. The market value of their outstanding shares is at $1.4 million. </li>
<li>TNF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) shares decreased by 23.0% to $0.19. The company's, Q4 earnings came out 3 days ago. </li>
<li>Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) stock declined by 16.99% to $32.5. The market value of their outstanding shares is at $3.8 billion. </li>
<li>Kiora Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPRX#NASDAQ">KPRX</a>) stock fell 11.35% to $2.5. The company's market cap stands at $7.5 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) shares decreased by 10.53% to $1.87. The company's market cap stands at $2.3 million. As per the press release, FY earnings came out 4 days ago. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) stock decreased by 9.44% to $0.64. The market value of their outstanding shares is at $21.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CYTK

JUNS

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

LCTX

RDHL

REVB

SXTC

SYRA

TNFA

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) stock rose 79.2% to $0.39 during Wednesday's after-market session. The market value of their outstanding shares is at $11.3 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares increased by 45.89% to $2.13. The company's market cap stands at $2.4 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) shares increased by 8.9% to $0.69. The company's market cap stands at $5.8 million. </li>
<li>Smith Micro Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares rose 5.06% to $0.94. The market value of their outstanding shares is at $16.6 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) shares increased by 4.86% to $0.68. The market value of their outstanding shares is at $12.3 million. </li>
<li>Indie Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) stock rose 4.83% to $1.95. The market value of their outstanding shares is at $358.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares declined by 10.6% to $1.61 during Wednesday's after-market session. The company's market cap stands at $41.6 million. </li>
<li>Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) stock decreased by 5.92% to $0.36. The market value of their outstanding shares is at $10.0 million. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares fell 5.28% to $0.13. The company's market cap stands at $9.3 million. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock decreased by 5.07% to $0.48. The company's, Q4 earnings came out 2 days ago. </li>
<li>Fatpipe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATN#NASDAQ">FATN</a>) stock fell 4.54% to $8.64. The market value of their outstanding shares is at $118.5 million. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares fell 4.0% to $7.7. The company's market cap stands at $46.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASNS

CMBM

FATN

GRYP

INDI

LIDR

SMSI

12 Information Technology Stocks Moving In Wednesday's After-Market Session

Biotech

GSK Plc Reveals That  CDC Advisory Panel Recommends PENMENVY for Inclusion in Adolescent Meningococcal Vaccination Schedule

Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>), a one-stop AI video solution provider, today announced that we have reached a strategic cooperation with Beijing Xinlantian Education Technology Co., Ltd. (hereinafter referred to as "Xinlantian"). This cooperation marks that Baijiayun, with its cutting - edge exploration in AI and large - language model technologies, will combine with Xinlantian's professional accumulation in the field of rehabilitation training for autistic children. Together, they will provide more efficient and personalized rehabilitation training programs for autistic children.
As the AI video technology service provider with the most in-depth comprehension of education, Baijiayun brings robust technical expertise in AI large model technologies. Xinlantian, through ten years of entrepreneurial experience, has accumulated specialized rehabilitation philosophies and a wealth of practical cases. The two parties will jointly develop an intelligent diagnostic assistance platform to create personalized rehabilitation plans tailored to each child's unique condition and training needs. Leveraging big data analytics and machine learning algorithms, the platform will enable real-time monitoring of training progress and outcomes. This precision-oriented approach ensures every child receives optimally customized rehabilitation programs, maximizing progress within shorter timeframes.
Additionally, Baijiayun will provide comprehensive support including SCRM management, online school platforms, intelligent diagnostics, and regulatory tools. These resources will empower Xinlantian to achieve refined management of parent leads, unified administration of teaching operations, real-time diagnosis of developmental challenges, and intelligent oversight of nationwide branches. Through these enhancements, Xinlantian will elevate service quality to deliver more holistic and professional rehabilitation services for autistic children and their families.

Baijiayun Group Forms Strategic Partnership With Xinlantian To Combine AI Video And Large Language Model Technologies With Decade-Long Expertise In Autism Rehabilitation, For Autistic Children Across China

Press Releases

Ionis reports fourth quarter and full year 2024 financial results

New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control

Ionis to present at upcoming investor conferences

WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy

Ionis and Ono announce global license agreement for sapablursen in polycythemia vera

Health Care

Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting

Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S.

Comments

Ionis Pharmaceuticals

Actualités

Dernières nouvelles pour Ionis Pharmaceuticals (NASDAQ:IONS) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL